Company Overview and News

21
Market Live: Sensex holds early gains; RIL gains 2% after Feb telecom data

2018-04-24 moneycontrol
11:59 am Crude Update: International oil prices hit their highest levels since late 2014, pushed up by expectations of renewed US sanctions against Iran and as OPEC continues withholding supplies amid strong demand.
500407 PIONDIST BHRYY JUBILANT 500325 RELIANCE 500405 TCHQY ICLQY 530019 BHRQY 532755 532710 THOMASCOOK 500470 532187 534816 RIGD 500477 INFRATEL SADBHAV BHARTIARTL RLNIY ASHOKLEY 500413 INDUSINDBK SWARAJENG 531879 533023 532822 AKLD TECHM ZENSARTECH 532454 504067 SUPPETRO TTST TATASTEEL TATLY IDEA WABCOINDIA DCMSHRIRAM AKLS 523367

17
Market Live: Sensex holds early gains; IT stocks decline, oil banks gain

2018-04-24 moneycontrol
10:50 am Recommendation: Reliance Securities said acquisition of Bharat Financial Inclusion has placed IndusInd Bank in a sweet spot. "With access to best-in-class microfinance business network along with scale and profitability, we envisage significant upside potential in terms of loan growth, fee income generation and CASA mobilisation, going forward."
500407 PIONDIST BHRYY JUBILANT 500325 RELIANCE 500405 TCHQY 530019 BHRQY 532755 532710 THOMASCOOK 500470 532187 534816 RIGD 500477 INFRATEL SADBHAV BHARTIARTL RLNIY ASHOKLEY 500413 INDUSINDBK SWARAJENG 531879 533023 AKLD TECHM ZENSARTECH 532454 504067 SUPPETRO TTST TATASTEEL TATLY WABCOINDIA DCMSHRIRAM AKLS 523367

15
Market Live: Sensex up 100 pts, Nifty nears 10,600 on Asian cues; metals melt

2018-04-24 moneycontrol
10:05 am Jubilant Life Sciences in focus: Jubilant Life Sciences share price gained 3.5 percent after the company has issued commercial papers (CPs) of Rs 75 crore on April 23.
500407 PIONDIST BHRYY JUBILANT 500325 RELIANCE 500405 TCHQY 530019 BHRQY 532755 532710 THOMASCOOK 500470 534816 RIGD 500477 INFRATEL SADBHAV BHARTIARTL RLNIY ASHOKLEY 500413 SWARAJENG 531879 AKLD TECHM ZENSARTECH 532454 504067 SUPPETRO TTST TATASTEEL TATLY DCMSHRIRAM AKLS 523367

 
Swaraj Engines Limited - Financial Result Updates

2018-04-24 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500407 SWARAJENG

 
Swaraj Engines Limited - Dividend

2018-04-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500407 SWARAJENG

 
Swaraj Engines Limited - Outcome of Board Meeting

2018-04-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500407 SWARAJENG

10
Upcoming results: CDSL, HDFC Bank, LIC Housing

2018-04-20 thehindubusinessline
The results season will kick off in earnest from this weekend with big companies declaring their quarter and full-year 2018 numbers. HDFC Bank, CDSL and Aro Granite will declare their numbers on Saturday, while 3i Infotech, Bharti Infratel, Bharat Financial Inclusion, Cholamandalam Investment, Delta Corp, Foseco India, GNFC, Indiabulls Ventures, Kewal Kiran, LIC Housing Finance, Reliance Infra, Reliance Naval & Engineering and Swaraj Engines will announce their results on Monday.
500407 FOSECOIND BHRYY IBVENTURES SWARAJENG TTNQY IDBLZ 532960 500150 532540 HDB 534816 LICHSGFIN 500180 HDFCBANK TCS INFRATEL LHFLY 500253

 
Swaraj Engines Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500407 SWARAJENG

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...